Schizophrenia

Addressing the mental health consequences of neuropsychiatric disorders

Latest practical psychopharmacology updates from the largest independent mental health educational

Long-acting injectables (LAIs) can provide numerous benefits throughout the continuum of care

Expert insights on the use of long-acting injectables in schizophrenia

Latest updates in psychopharmacology and future-focused education

Which patient groups can be treated with long-acting injectables?

Adherence in schizophrenia: Do providers know when their patients are non-adherent?

How does the overestimation of patient fears around LAIs impact the decision to present these

Clinical dilemmas, schizophrenia treatment and the potential role of LAIs